• The New Money
  • Posts
  • Drugs From Space, Canada Pumps Billions Into AI, and Nevada Lithium

Drugs From Space, Canada Pumps Billions Into AI, and Nevada Lithium

Uncovering the world’s most exciting early stage companies. Discover what’s next.

April 09, 2024

The Startup Disrupting Drug Development In Space

Varda Space has purpose-built a satellite and re-entry vehicle that can bring materials back safely from space, unlocking the ability to process materials in microgravity which has significant benefits for pharmaceutical research. The company raised $90 million in a Series B financing round from notable venture capital firms including Lux Capital, Khosla Ventures, and Founders Fund.

Canada Is Pumping Billions Into Computing Power For AI

The Canadian government has announced a new funding plan to put $2.4 billion CAD into accelerating artificial intelligence by securing computing power for startups and researchers, and another $405 million of funding that will help startups commercialize their AI applications.

Going All In On Lithium In Nevada

Canter Resources (CSE:CRC) has expanded their land package at the company’s flagship Nevada lithium property to nearly 30,000 acres following the results of a comprehensive subsurface 3D modelling project. Nevada has been one of the most abundant regions in the United States for battery grade lithium, and Canter’s property was originally staked by some of the most successful prospectors in the state.

The Sprint

New here? Join our community of 25,000+ individuals interested in uncovering the world’s most exciting early stage companies.

Disclaimer: The New Money provides background information on early stage companies from publicly available sources. The New Money provides no advice on dealing in securities, is not a financial adviser and does not pretend to be so. This message is meant for information and educational purposes only. The information contained in this email is not to be considered factual or complete. Anybody interested in obtaining financial and other information on companies mentioned is advised to get it direct from the companies, or from their own investment adviser. The New Money does not intend for this information to be used to inform an investment decision. The New Money has been compensated by some of the companies mentioned in this email for awareness campaigns, which affects our ability to be unbiased. The Principals of The New Money may buy or sell shares of the mentioned companies without further notice. This is why we stress that you conduct extensive due diligence as well as seek the advice of your financial advisor or a registered broker-dealer before investing in any securities. The New Money and its principals and agents are not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Always do your own research and consult with a licensed investment professional before making an investment. This communication should not be used as a basis for making any investment. Investing is inherently risky. While a potential for rewards exists, by investing, you are putting yourself at risk. You must be aware of the risks and be willing to accept them in order to invest in any type of security. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy or Sell securities. No representation is being made that any stock trade will or is likely to achieve profits. Comparisons made to other featured companies or past performance is not indicative of future results.